Cancer Prevention Pharmaceuticals, Inc Email Format

Biotechnology ResearchArizona, United States2-10 Employees

Cancer Prevention Pharmaceuticals, Inc. is a biotechnology research company focused on developing therapeutics aimed at reducing cancer risk and recurrence, including preventive treatments for gastrointestinal cancers, pediatric cancers, and early-onset type 1 diabetes. Its approach centers on targeting polyamine synthesis and inflammation, two processes linked to cancer development, with the implication of applying these pathways together to address cancer precursors. The company collaborates with research institutions and nonprofit groups to support clinical trials in various cancers and related conditions, and it maintains partnerships with major regulatory and research organizations to advance prevention therapies. Based in Tucson, Arizona, CPP operates with a small team and engages in partnerships with larger entities in the industry to move its lead product CPP-1X/sul through pivotal and Phase 3 trials for familial adenomatous polyposis and supportive studies for colon cancer survivors. A notable development in its history is the licensing agreement with Mallinckrodt for North American commercialization rights to CPP-1X/sul, reflecting a key step in advancing its therapeutic agenda.

Get verified Cancer Prevention Pharmaceuticals, Inc emails free

Company overview Employee directory